Dr. Scott Campbell received his Ph.D. in Basic Biomedical Sciences in 1985 from the University of South Florida.  Following postdoctoral training in cardiovascular physiology at the University of Ottawa in Canada, he spent 12 years in academia at the Michael Reese Hospital in Chicago, the University of Missouri and the University of South Dakota where his primary area of research interest was hypertension, heart failure and the renin-angiotensin system.  He is the author of 41 peer-reviewed articles, 9 invited reviews and 14 book chapters.

Dr. Campbell joined the American Diabetes Association in 2001 as National Vice President of Research Programs.  In addition to overseeing all research-related programs at the ADA, he was also responsible for helping acquire major donations to the ADA Research Foundation.  He had primary responsibility for oversight of the ADA Research Grant Review Committee, Research Policy Committee, and Scientific and Healthcare Council.  He also reported to both the ADA National Board of Directors and the ADA Research Foundation Board.  He served as liaison for the ADA to federal research efforts at the NIH, VA, CDC and FDA.  In that capacity, he also was invited to provide input to the strategic planning efforts of the NIH National Center for Research Resources and the National Institute of Diabetes, Digestive and Kidney Disease.  Internationally, Dr. Campbell was the ADA Research Program liaison to the European Association for the Study of Diabetes (EASD) and the International Diabetes Federation (IDF).  He also serves as a Senior Consultant to the China-America Institute of Diabetic Complications in the School of Pharmacy, Wenzhou Medical College.

Dr. Campbell represented the ADA on numerous external panels/committees.  He served as a member of the Board of Trustees for the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC); as a member of the Institute of Medicine’s Clinical Research Roundtable; and is a current member of the Forum on Drug Discovery, Development, and Translation for the Institute of Medicine at the National Academies.  He also served until recently on the Board of Directors for the Health Research Alliance, as well as Treasurer for this organization.